Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CIS

被引：0
|
作者：
Plambeck, Benjamin D. [1 ]
Tazegul, Tutku E. [2 ]
Mcelree, Ian M. [2 ]
Steinberg, Ryan L. [1 ]
Packiam, Vignesh T. [1 ]
'Donnell, Michael A. O. [1 ,3 ]
机构：
[1] Univ Iowa Hosp & Clin, Dept Urol, Iowa City, IA USA
[2] Univ Iowa, Carver Coll Med, Iowa City, IA USA
[3] Univ Iowa Hosp & Clin, Dept Urol, 200 Hawkins Dr, Iowa City, IA 52242 USA
来源：
UROLOGY CASE REPORTS | 2023年 / 50卷
关键词：
Muscle invasive bladder cancer; Carcinoma in situ; Partial cystectomy; Gemcitabine; Docetaxel;
D O I：
10.1016/j.eucr.2023.102516
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The presence of carcinoma in situ (CIS) is traditionally a contraindication to bladder-sparing approaches for muscle invasive bladder cancer (MIBC). Strategies that might aid in bladder preservation for this population require further investigation. We report a case of MIBC with CIS treated with both neoadjuvant systemic and intravesical chemotherapy prior to partial cystectomy.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] NEOADJUVANT CHEMOTHERAPY AND PARTIAL CYSTECTOMY FOR INVASIVE BLADDER-CANCER
    HERR, HW
    SCHER, HI
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (05) : 975 - 980
  • [2] The Case for Neoadjuvant Chemotherapy and Cystectomy for Muscle Invasive Bladder Cancer
    White, Ralph W. deVere
    [J]. JOURNAL OF UROLOGY, 2009, 181 (05): : 1994 - 1995
  • [3] Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trials
    Gabrielson, Andrew T.
    Daniels, Marcus J.
    Rowe, Julian
    Alam, Ridwan
    Lee, Esther J.
    Matoso, Andres
    De Felice, Anthony
    Hahn, Noah
    Hoffman-Censits, Jean
    Bivalacqua, Trinity J.
    Kates, Max
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (04) : 164.e9 - 164.e16
  • [4] Neoadjuvant Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer
    Messing, Edward M.
    [J]. BLADDER CANCER, 2023, 9 (02) : 191 - 192
  • [5] The Case Against Neoadjuvant Chemotherapy and Cystectomy for Muscle Invasive Bladder Cancer
    Katz, Mark H.
    Steinberg, Gary D.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (05): : 1995 - 1997
  • [6] Clinical application and efficacy analysis of partial cystectomy combined with intravesical chemotherapy in muscle-invasive bladder cancer
    Bin Zhang
    Tengfei Liu
    Yang He
    Dali Han
    Peng Qi
    Duo Zheng
    Junyao Liu
    Xingxing Zhang
    Zhongjin Yue
    Panfeng Shang
    [J]. BMC Urology, 23
  • [7] Clinical application and efficacy analysis of partial cystectomy combined with intravesical chemotherapy in muscle-invasive bladder cancer
    Zhang, Bin
    Liu, Tengfei
    He, Yang
    Han, Dali
    Qi, Peng
    Zheng, Duo
    Liu, Junyao
    Zhang, Xingxing
    Yue, Zhongjin
    Shang, Panfeng
    [J]. BMC UROLOGY, 2023, 23 (01)
  • [8] Systemic Treatment for Invasive Bladder Cancer: Neoadjuvant Chemotherapy and Laparoscopic Radical Cystectomy
    Barret, Eric
    Sanchez-Salas, Rafael
    Vallancien, Guy
    [J]. INTERNATIONAL BRAZ J UROL, 2008, 34 (04): : 513 - 515
  • [9] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Complications and impact on cystectomy
    Neuzillet, Y.
    [J]. PROGRES EN UROLOGIE, 2015, 25 (09): : 555 - 556
  • [10] Chemotherapy and cystectomy for muscle invasive bladder cancer
    Grossman, HB
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (06) : 463 - 463
12345